Effectiveness of biosimilar drugs in the treatment of renal anemia: A case series
Introduction Patients with chronic kidney disease usually have anemia secondary to an erythropoietin deficit. The emergence of biosimilar drugs of erythropoiesis-stimulating agents ensures broader access to these treatments. Objective This study analyzes the effectiveness of an epoetin α biosim...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN ES |
Publicado: |
Medwave Estudios Limitada
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a2ce73468f3043b2a5060f8e35081468 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Sea el primero en dejar un comentario!